200670.KQ WACC - Weighted Average Cost of Capital
The WACC of Humedix Co Ltd (200670.KQ) is 7.0%.
| Range | Selected | |
| Cost of equity | 5.9% - 8.1% | 7% |
| Tax rate | 17.4% - 20.7% | 19.05% |
| Cost of debt | 5.0% - 5.0% | 5% |
| WACC | 5.9% - 8.0% | 7.0% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.48 | 0.58 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.9% | 8.1% |
| Tax rate | 17.4% | 20.7% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 5.0% | 5.0% |
| After-tax WACC | 5.9% | 8.0% |
| Selected WACC | 7.0% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| 200670.KQ | Humedix Co Ltd | 0.01 | 0.49 | 0.48 |
| 000220.KS | Yuyu Pharma Inc | 0.37 | 0.29 | 0.22 |
| 002210.KS | Dongsung Pharmaceutical Co Ltd | 0.72 | -0.24 | -0.15 |
| 002720.KS | Kukje Pharma Co Ltd | 0.29 | 0.22 | 0.18 |
| 004310.KS | Hyundai Pharmaceutical Co Ltd | 0.43 | 0.02 | 0.01 |
| 004720.KS | Wooridul Pharmaceutical Ltd | 0.51 | 0.55 | 0.39 |
| 006620.KQ | DongKoo Bio & Pharma Co Ltd | 0.54 | 0.53 | 0.37 |
| 063160.KS | CKD Bio Corp | 1.05 | 0.43 | 0.23 |
| 067080.KQ | Dae Hwa Pharm Co Ltd | 0.39 | 1.43 | 1.09 |
| 067290.KQ | JW Shinyak Corp | 0.15 | 0.47 | 0.42 |
| Low | High | |
| Unlevered beta | 0.23 | 0.38 |
| Relevered beta | 0.22 | 0.37 |
| Adjusted relevered beta | 0.48 | 0.58 |
200670.KQ's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 200670.KQ:
cost_of_equity (7.00%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.48) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.